ArticleHeliyon2023
Impact of COVID-19 on investor sentiment in China's stock markets.
Article in Heliyon, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Large-scale public health emergencies may exert significant adverse effects on market sentiment. This study utilizes interrupted time series analysis (ITSA) to explore the shift in Chinese investors' sentiment in response to the uncertainties due to the outbreak of the COVID-19 pandemic. The empirical findings demonstrate that COVID-19 had a notable impact on investor sentiment within China's stock markets. Before the outbreak of COVID-19, investor sentiment had been on an upward trend. However, since the onset of the pandemic, there has been a sustained decline in investor sentiment, aligning with the downward trend observed in China's stock markets. Interestingly, the immediate effect of the COVID-19 intervention was positive, briefly boosting investor sentiment. As of 2023, with the conclusion of the pandemic and the Chinese government's decision to end the zero COVID-19 policy, we anticipate resurgence in investor sentiment within China's stock markets.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.